Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact Us
 
Early Edition  //  Current Issue  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited

Online ISSN 2521-8743
  About the Journal
    » About Journal
    » Editorial Board
  Authors
    » Online Submission
    » Guidelines for Authors
    » Download Templates
    » Copyright Agreement
  Reviewers
    » Guidelines for Reviewers
    » Online Peer Review
    » Online Editor Work
  Editorial Office
  Virtual Special Issues
     COVID-19

Default Latest Most Read
Please wait a minute...
For Selected: Toggle Thumbnails
Hydroxychloroquine for the Treatment of Coronavirus Disease 2019: Evidence, Possible Mode of Action and Industrial Supply
Mario Pagliaro, Francesco Meneguzzo
Medicine Research    2020, 4 (3): 200014-.   DOI: 10.21127/yaoyimr20200014
Abstract393)      PDF (678KB)(495)       Save
Hydroxychloroquine, a known antiviral metabolite of chloroquine, is increasingly used along with antibiotic azithromycin for the treatment of COVID-19 infection. In about one month, India, the world’s largest manufacturer, delivered the pharmaceutical ingredient for treating COVID-19 to over 50 countries. Coupled to azithromycin, the therapy is being used across the world both for patients staying at home at the early phase of symptoms, as well as for patients hospitalized. We summarize achievements as of late April 2020, review possible modes of action and suggest avenues for the quick scale-up of production of hydroxychloroquine.
Reference | Related Articles | Metrics
沪ICP备15041762号-3
Copyright © Medicine Research, All Rights Reserved.
Address: 425 East 76th Street, Apt 9E, New York, NY, 10021, United States